TLR1 and B-cell non-Hodgkin lymphoma: On the contrary, consistent with the findings of this study, Pam3CSK4 synergized with Ara-C in killing B cell lymphoma cells and it triggered apoptosis of acute myeloid leukemia (AML) cells indicating possible context-dependent activation effects of TLR1/2 activation [30, 31].